Viral hepatitis is a major cause of morbidity and mortality, affecting
hundreds of millions of people worldwide. Hepatitis-causing viruses initiate
disease by establishing both acute and chronic infections, and several of these
viruses are specifically associated with the development of hepatocellular
carcinoma. Consequently, intense research efforts have been focusing on
increasing our understanding of hepatitis virus biology and on improving
antiviral therapy and vaccination strategies. Although valuable information on
viral hepatitis emerged from careful epidemiological studies on sporadic
outbreaks in humans, experimental models using cell culture, rodent and
non-human primates were essential in advancing the field. Through the use of
these experimental models, improvement in both the treatment and prevention of
viral hepatitis has progressed rapidly; however, agents of viral hepatitis are
still among the most common pathogens infecting humans. In this Review, we
describe the important part that these experimental models have played in the
study of viral hepatitis and led to monumental advances in our understanding and
treatment of these pathogens. Ongoing developments in experimental models are
also described.